Pharmacogenetics of Warfarin in a Paediatric Population: Time in Therapeutic Range, Initial and Stable Dosing and Adverse Effects

Pharmacogenomics Journal - United Kingdom
doi 10.1038/tpj.2014.31
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Evaluating Time in Therapeutic Range for Hemodialysis Patients Taking Warfarin

Clinical Nephrology
MedicineNephrology
2015English

Identification of Environmental and Genetic Factors That Influence Warfarin Time in Therapeutic Range

Genetics and Molecular Biology
GeneticsMolecular Biology
2020English

Impact of Aspirin on Warfarin Control as Measured by Time in Therapeutic Range

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries

Thrombosis and Haemostasis
Hematology
2017English

Pharmacogenetics of Warfarin: Challenges and Opportunities

Journal of Human Genetics
Genetics
2013English

Using Pharmacogenetics in Real Time to Guide Warfarin Initiation: A Clinician Update

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Comparison of Initial Warfarin Dosing in Hospitalised Patients Considered Sensitive to Warfarin: Low‐dose Versus Standard‐dose Strategy

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2019English

Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin

Frontiers in Pharmacology
Pharmacology
2018English

Pharmacogenetics and Antipsychotics: Therapeutic Efficacy and Side Effects Prediction

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy